Lung Transplant for the Critical Care Nurse - 26/07/19
Résumé |
Lung transplantation is an established treatment of select patients with end-stage pulmonary disease. Lung transplantation should be considered for patients with end-stage pulmonary disease who have an expected 2-year survival of less than 50% without lung transplant and an expected 5-year survival of greater than 80% after transplant. This article reviews routine postsurgical intensive care unit management, along with management of complications such as acute kidney injury, atrial arrhythmias, deep vein thrombosis, primary graft dysfunction, hyperammonemia syndrome, and thrombocytopenia. Finally, management of long-term issues, including diabetes mellitus, hypertension, and bronchial stenosis, is discussed.
Le texte complet de cet article est disponible en PDF.Keywords : Lung transplant, Respiratory failure, Immunosuppression, ECMO, Cardiothoracic surgery
Plan
Disclosure Statement: The authors have nothing to disclose. |
|
The authors have no financial conflicts of interest and have not received funding for this article. |
Vol 31 - N° 3
P. 285-302 - septembre 2019 Retour au numéroBienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?